AI-Optimized Clinical Trials
PhaseV (phasevtrials.com) earns a Brand Analyzer score of 68 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands, Technology brands. Among 2305 Healthcare brands analyzed, PhaseV ranks in the 49th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 97/100, Digital Presence 76/100, Visual Identity 93/100, Messaging Clarity 88/100, Trust Foundation 66/100, AI Discoverability 70/100, Brand Authority 18/100.
PhaseV is an AI/ML-driven software platform designed for biopharma sponsors and contract research organizations (CROs). It supports clinical development decisions by running millions of simulations in minutes, benchmarking Bayesian designs, and enabling real-time data-driven trial decisions. The platform also optimizes subgroups, biomarkers, and portfolios to improve trial outcomes and return on investment. PhaseV is positioned as a leading AI/ML solution for faster and more accurate clinical trials in the biopharma industry.
| Brand Name | PhaseV |
|---|---|
| Domain | phasevtrials.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Medidata Solutions, Veeva Systems (81/100), ICON plc (84/100), Certara (87/100), Saama Technologies, Unlearn.AI |
Moz Domain Authority 25/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions for fast, efficient, and accurate clinical development decisions." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, YouTube, GitHub; no detected presence on X (Twitter), Facebook, Instagram - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
PhaseV scores 24/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
PhaseV has a weak AI-visibility profile at 24/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 25/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
PhaseV's main competitors include Medidata Solutions, Veeva Systems (81/100), ICON plc, Certara, Saama Technologies. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: PhaseV official site
PhaseV and Veeva Systems are competitors in Healthcare. Brand Analyzer scores PhaseV at 68/100 and Veeva Systems at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: PhaseV official site
Popular alternatives to PhaseV include Medidata Solutions, Veeva Systems (81/100), ICON plc, Certara, Saama Technologies. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: PhaseV official site
PhaseV has low AI-search visibility, scoring 24/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: PhaseV official site
PhaseV uses artificial intelligence and machine learning to support clinical trial decision-making. The platform runs millions of simulations in minutes, benchmarks Bayesian trial designs, and facilitates real-time data-driven decisions during clinical development. It also optimizes subgroups, biomarkers, and drug development portfolios to improve trial outcomes and maximize return on investment for biopharma sponsors and CROs.
Sources: PhaseV official site
PhaseV is an AI/ML-driven software platform serving biopharma sponsors and contract research organizations (CROs). It is positioned as a leading technology solution for smarter, faster clinical trials in the biopharma sector, falling within the Healthcare, SaaS, and Technology categories. The platform is accessible via phasevtrials.com and focuses on enabling fast, efficient, and accurate clinical development decisions through advanced simulation and machine learning capabilities.
Sources: PhaseV official site
Based on available information, PhaseV offers an AI/ML-driven platform for clinical development. Its capabilities include running millions of simulations in minutes, benchmarking Bayesian trial designs, enabling real-time data-driven trial decisions, and optimizing subgroups, biomarkers, and drug development portfolios. These features are aimed at helping biopharma sponsors and CROs make faster and more accurate clinical development decisions while improving trial ROI.
Sources: PhaseV official site
PhaseV's stated target audience is biopharma sponsors and contract research organizations (CROs). These are organizations involved in the design, management, and execution of clinical trials for pharmaceutical and biopharmaceutical drugs. The platform is specifically built to serve decision-makers within these entities who require fast, efficient, and accurate tools for clinical development planning and trial optimization.
Sources: PhaseV official site
PhaseV scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: PhaseV official site
PhaseV can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: PhaseV official site
PhaseV is known for its AI and ML-driven approach to clinical trial optimization. Specifically, it is recognized for its ability to run millions of simulations in minutes, its benchmarking of Bayesian trial designs, and its real-time data-driven decision support. The platform is also noted for optimizing subgroups, biomarkers, and portfolios to enhance both trial outcomes and the return on investment for clinical development programs.
Sources: PhaseV official site
Ranked closest to PhaseV: PAX-it (68/100), PartsSource (68/100), Phrase Health (68/100), Smarter Technologies (68/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).